ARA-290

ARA-290 is an investigational peptide derived from a specific region of erythropoietin (EPO) and designed to explore tissue-protective and regenerative pathways without the primary red-blood-cell–stimulating effects associated with EPO.

Research into ARA-290 has focused on its potential role in supporting cellular protection, reducing inflammatory signaling, and promoting recovery in tissues affected by injury or metabolic stress. Preclinical and early clinical research has explored its activity across several areas, including nerve and tissue function.

Important Note: ARA-290 is intended for research purposes only and should not be used for human consumption or self-administration. Always ensure compliance with local regulations when handling peptides.